Stallergenes Greer Initiates a European Paediatric Phase III Study With Staloral® Birch
BAAR, Switzerland–(BUSINESS WIRE)– Stallergenes Greer, a biopharmaceutical company specialising in the diagnosis and treatment of respiratory allergies, announced today the initiation of a Phase III...